[HTML][HTML] Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential

R Guo, LH Chen, C Xing, T Liu - British journal of anaesthesia, 2019 - Elsevier
The relationship between gut microbiota and neurological diseases, including chronic pain,
has received increasing attention. The gut microbiome is a crucial modulator of visceral …

[HTML][HTML] Nonalcoholic fatty liver disease and aging: epidemiology to management

M Bertolotti, A Lonardo, C Mussi, E Baldelli… - World journal of …, 2014 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is common in the elderly, in whom it carries a more
substantial burden of hepatic (nonalcoholic steatohepatitis, cirrhosis and hepatocellular …

[HTML][HTML] Naloxegol for opioid-induced constipation in patients with noncancer pain

WD Chey, L Webster, M Sostek… - … England Journal of …, 2014 - Mass Medical Soc
Background Opioid-induced constipation is common and debilitating. We investigated the
efficacy and safety of naloxegol, an oral, peripherally acting, μ-opioid receptor antagonist, for …

European Pain Federation position paper on appropriate opioid use in chronic pain management

T O'Brien, LL Christrup, AM Drewes… - … Journal of Pain, 2017 - Wiley Online Library
Poorly controlled pain is a global public health issue. The personal, familial and societal
costs are immeasurable. Only a minority of European patients have access to a …

Epidemiology of constipation in North America: a systematic review

PDR Higgins, JF Johanson - … journal of the American College of …, 2004 - journals.lww.com
OBJECTIVE The aim of this study was to systematically review the published literature
regarding prevalence, risk factors, incidence, natural history, and the effect on quality of life …

The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1)

TJ Bell, SJ Panchal, C Miaskowski, SC Bolge… - Pain …, 2009 - academic.oup.com
ABSTRACT Objective. This multinational, Internet-based survey was designed to assess the
prevalence, frequency, severity, and impact of opioid-induced bowel dysfunction (OBD) in …

[HTML][HTML] Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines

PJ Larkin, NI Cherny, D La Carpia, M Guglielmo… - Annals of oncology, 2018 - Elsevier
Constipation is a common problem in patients with advanced cancer and a significant
source of major morbidity and distress, which is often under-appreciated [1]. Constipation is …

Opioid-induced constipation and bowel dysfunction: a clinical guideline

S Müller-Lissner, G Bassotti, B Coffin… - Pain …, 2017 - academic.oup.com
Objective To formulate timely evidence-based guidelines for the management of opioid-
induced bowel dysfunction. Setting Constipation is a major untoward effect of opioids …

Bupivacaine extended-release liposome injection for prolonged postsurgical analgesia in patients undergoing hemorrhoidectomy: a multicenter, randomized, double …

SR Gorfine, E Onel, G Patou… - Diseases of the colon & …, 2011 - journals.lww.com
BACKGROUND: Bupivacaine extended-release liposome injection is a novel formulation of
bupivacaine designed to achieve long-acting postoperative analgesia. OBJECTIVE: The aim …

Opioid-induced bowel dysfunction: pathophysiology and potential new therapies

A Kurz, DI Sessler - Drugs, 2003 - Springer
Opioid treatment for postoperative or chronic pain is frequently associated with adverse
effects, the most common being dose-limiting and debilitating bowel dysfunction …